Fatima H Karzai, M.D.

Trials

Studies that name Fatima H Karzai, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:51 UTC. Open this list on ClinicalTrials.gov

• N/A
  NCT04706663 · Precision-Based Genomics in Prostate Cancer

  National Cancer Institute (NCI) · recruiting · Prostate Cancer · principal investigator
• Ph1
  NCT04296942 · BN-Brachyury, Entinostat, Adotrastuzumab Emtansine and M7824 in Advanced Stage Breast Cancer (BrEAsT)

  National Cancer Institute (NCI) · terminated · Breast Cancer, Triple Negative Breast Cancer, HER2+ Breast Cancer · principal investigator
• Ph2
  NCT03976843 · Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer

  National Cancer Institute (NCI) · active not recruiting · Prostate Cancer · principal investigator
• Ph2
  NCT03860987 · Neoadjuvant Androgen Deprivation Therapy Combined With Enzalutamide and Abiraterone Using Multiparametric MRI and 18FDCFPyL PET/CT in Newly Diagnosed Prostate Cancer

  National Cancer Institute (NCI) · completed · Castrate Sensitive Prostate Cancer · principal investigator
• N/A
  NCT03805919 · Men at High Genetic Risk for Prostate Cancer

  National Cancer Institute (NCI) · recruiting · Prostatic Neoplasms · principal investigator
• N/A
  NCT00923065 · Data Collection, Clinical Care and Interventions in CCR, NCI

  National Cancer Institute (NCI) · enrolling by invitation · Neoplasms, Cancer · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 11:51 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.